Read-Gene S.A. (WSE:RDG)
Poland · Delayed Price · Currency is PLN 5.06
-0.22 (-4.17%)
At close: May 22, 2026
Read-Gene Market Cap
Read-Gene has a market cap or net worth of 59.66 million as of May 22, 2026. Its market cap has increased by 15.00% in one year.
Market Cap
59.66M
Enterprise Value
62.79M
Revenue
15.57M
Ranking
n/a
PE Ratio
73.80
Stock Price
5.06
Market Cap Chart
Since February 12, 2009, Read-Gene's market cap has increased from 31.83M to 59.66M, an increase of 87.41%. That is a compound annual growth rate of 3.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 59.66M | -7.33% |
| Dec 30, 2025 | 64.37M | 10.08% |
| Dec 30, 2024 | 58.48M | -14.48% |
| Dec 29, 2023 | 68.38M | 124.81% |
| Dec 30, 2022 | 30.42M | -8.19% |
| Dec 29, 2021 | 33.13M | 8.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.44B |
| NEUCA | 3.30B |
| Synektik Spólka Akcyjna | 2.41B |
| Celon Pharma | 1.11B |
| NanoGroup | 101.03M |
| Poltreg | 91.87M |
| Genomtec | 91.74M |
| Urteste | 62.31M |